Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

RayPilot HypoCath_ Next Generation real-time tumor tracking for radiotherapy against prostate cancer

Reference number
Coordinator MICROPOS MEDICAL AB (PUBL) - Micropos Medical AB
Funding from Vinnova SEK 500 000
Project duration December 2018 - May 2019
Status Completed

Purpose and goal

Phase II application is completed, submitted and evaluated by the EU Commission. Obtained 13.42 points (threshold 13) but became rejected to proceed in the process. A new revised Phase II application is expected to be submitted at the beginning of June 2019.

Expected results and effects

Phase II application is completed, submitted and evaluated by the EU Commission. Obtained 13.42 points (threshold) but became rejected to proceed in the process. A new revised Phase II application is expected to be submitted at the beginning of June 2019.

Planned approach and implementation

Analysis for a revised new application is underway with the aim of submitting a new application at the beginning of June 2019.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 22 November 2018

Reference number 2018-04732

Page statistics